Popular Articles

Improvement In Long-Term Survival From Abdominal Aortic Aneurysm Repair
Long-term survival for patients undergoing surgical repair of intact abdominal aortic aneurysms has improved in recent decades, according to a Swedish study reported in Circulation: Journal of the American Heart Association.
drugs without prescription
Lawmakers Seek Compromise On Health Overhaul Proposals
Democrats and Republicans are saying that they will need to compromise on a government-run public plan if they are to meet the deadline of having a bill on the Senate floor by the August recess, The Associated Press reports.
News of the day
Cubist Pharmaceuticals Initiates Phase 2 Trial In Europe For Therapy To Reduce Blood Loss During Surgery In High Risk Patients
Cubist Pharmaceuticals, Inc. (Nasdaq: CBST), a leading acute care therapeutics company, announced that it has begun dosing in the CONSERV™-2 clinical trial with ecallantide. CONSERV-2, being conducted in Europe, is a Phase 2 trial that will investigate ecallantide"s effect on surgical blood loss volume in cardiac surgery patients who are on cardiopulmonary bypass and are at a high risk of bleeding. The trial is expected to enroll 300 subjects.
Oncology

California HIV/AIDS Advocates Continue To Protest Proposed Funding Cuts

On Monday, HIV/AIDS advocates staged a rally in Fresno, Calif., to protest a budget proposal by Gov. Arnold Schwarzenegger (R) that would cut an estimated $80 million statewide in HIV/AIDS services, KMPH.com reports. The proposed cuts would eliminate or reduce funding for HIV testing services, financial assistance for people living with HIV and other programs, according to KMPH.com. A larger rally at the state capitol is planned for Wednesday (KMPH.com. 6/9). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):